Table 2.
Biological activities and physicochemical properties of series 6 and 7
![]() | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R1 | R2 | IC50 (µM)a Mer TK |
GI50 (µM)b | Propertyc | ||||||
| A549 | KB | KB-vin | DU145 | MV4-11 | Aq. Sol. (µ g/mL) |
Log P | ||||
| 4a | OMe | 1.08 | 10.1 | 11.1 | 12.6 | 12.4 | 4.91 | 10.4 | >5 | |
| 6a | CN | >30 | >31.3 | >31.3 | >31.3 | >31.3 | NDd | ND | ND | |
| 6b | NH2 | 7.27 | 15.9 | 17.4 | 21.7 | 18.7 | 4.42 | ND | ND | |
| 6c | F | 4.17 | 12.8 | 13.8 | 12.3 | 9.9 | 5.43 | 1.54 | >5 | |
| 6d | OH | 1.24 | 14.8 | 12.1 | 13.6 | 14.3 | 3.00 | 3.10 | 3.95 | |
| 6e | COOH | 2.90 | 28.7 | 25.2 | 19.8 | 27.3 | 7.50 | ND | ND | |
| 4b | OMe | 0.68 | 15.2 | 20.3 | 17.1 | 18.3 | 8.75 | 95.6 | 2.54 | |
| 7a | CN | 1.72 | 3.00 | 23.7 | 4.31 | 18.7 | 2.79 | 7.52 | 2.84 | |
| 7b | NH2 | >30 | 17.1 | 19.7 | 18.7 | 20.8 | ND | ND | ND | |
| 7c | F | >30 | 19.3 | 17.1 | 24.2 | 20.6 | ND | ND | ND | |
| 7d | F | 7.84 | 4.3 | 2.9 | 2.5 | 4.2 | ND | ND | ND | |
| 7e | F | >30 | ND | ND | ND | ND | ND | ND | ND | |
| 7f | NH2 | >30 | ND | ND | ND | ND | ND | ND | ND | |
| Staurosporinee | 0.00081 | |||||||||
| Paclitaxel (nM)e | 4.9 | 2.6 | 948 | 2.6 | ||||||
IC50 is concentration that inhibits 50% Mer tyrosine kinase;
GI50 is concentration that inhibits 50% human tumor cell growth, and the values were averaged values determined by at least three independent experiments;
active compounds with IC50 <10 µM and GI50 <20 µM were measured by the methods in Reference 19;
not detected;
reference compounds as the passitive control in related assays.
